Drug
Kk2845 1
Kk2845 1: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KK2845_1 NCT06812104 | Phase 1 | Relapsed or Refractory AML and Other Hematologic Malignancies |
Latest
No recent events.
Follow Kk2845 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.